Analyst Ratings for BridgeBio Pharma (BBIO) [Buys]

BBIO Rating Summary

BBIO Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BBIO
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $81.29 (+37%) * Over Last 12-Mos
Rating Score: 9.2 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/21/2021 UBS Eliana Merle New Coverage Buy
(N/A)
80.00
(N/A)
54.97
(59.35)
7.97% Details
2/22/2021 JPMorgan Anupam Rama New Coverage Overweight
(N/A)
78.00
(N/A)
63.85
(59.35)
-7.05% Details
Like BBIO Ratings? Also take a look at EIDX, PRTA, ON, PEGA

BBIO Ratings News